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APPL Proteins Link Rab5 to Nuclear Signal
Transduction via an Endosomal Compartment
view, signal transduction is initiated at the plasma mem-
brane and, via a series of protein-protein interactions
and kinase cascades, transmitted through the cyto-
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and their degradation in the lysosomes. The idea thatPfotenhauerstrasse 108
endosomes can perform a signaling function received01307 Dresden
support by studies of NGF action in neurons (GrimesGermany
et al., 1996). More recently, an increasing number of2 European Molecular Biology Laboratory
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tionally distinct signaling complexes with activated re-69117 Heidelberg
ceptors along their intracellular itinerary through variousGermany
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arguing against such a role (Johannessen et al., 2000;Pfotenhauerstrasse 110
Kao et al., 1998; Lu et al., 2002). On the other hand,01307 Dresden
there is compelling evidence that signaling pathwaysGermany
can modulate the endocytosis machinery, as exempli-
fied by the recently uncovered functional connections
between the small GTPase Rab5 and signaling mole-Summary
cules (Barbieri et al., 2000; Lanzetti et al., 2000; Tall et
al., 2001). Rab5 is a key regulator of transport from the
Signals generated in response to extracellular stimuli
plasma membrane to the early endosomes. Continuous
at the plasma membrane are transmitted through cy- cycles of GDP/GTP exchange and hydrolysis regulate
toplasmic transduction cascades to the nucleus. We the kinetics of constitutive endocytosis (Rybin et al.,
report the identification of a pathway directly linking 1996) but this nucleotide cycle can also be modulated
the small GTPase Rab5, a key regulator of endocyto- by extracellular stimuli. Stimulation by EGF enhances
sis, to signal transduction and mitogenesis. This path- the rate of endocytic membrane flow (Barbieri et al.,
way operates via APPL1 and APPL2, two Rab5 2000) by increasing the fraction of active Rab5 through
effectors, which reside on a subpopulation of endo- stimulation of the Rab5 guanine nucleotide exchange
somes. In response to extracellular stimuli such as factor (GEF) RIN1 (Tall et al., 2001) and downregulation
EGF and oxidative stress, APPL1 translocates from of the GTPase-activating protein (GAP) RN-tre (Lanzetti
the membranes to the nucleus where it interacts with et al., 2000). Beside regulating receptor internalization
the nucleosome remodeling and histone deacetylase (Lanzetti et al., 2000), RN-tre is also integrated into the
multiprotein complex NuRD/MeCP1, an established EGF signaling pathway via its interactions with the EGF
regulator of chromatin structure and gene expression. receptor (EGFR) substrate Eps8 and the adaptor protein
Both APPL1 and APPL2 are essential for cell prolifera- Grb2, which links EGFR to mSos, a GEF for Ras (Lanzetti
tion and their function requires Rab5 binding. Our find- et al., 2000; Martinu et al., 2002).
ings identify an endosomal compartment bearing The molecular principles underlying the structural and
Rab5 and APPL proteins as an intermediate in signal- functional organization of early endosomes are also inti-
ing between the plasma membrane and the nucleus. mately linked to the function of signaling molecules. On
the early endosomes, Rab5 regulates the membrane
recruitment and activity of a wide range of downstreamIntroduction
effectors (Bucci et al., 1992; Christoforidis et al., 1999a;
Rubino et al., 2000), such as Rabaptin-5/5/Rabex-5,In response to extracellular stimuli cells activate an intri-
EEA1, Rabenosyn-5/hVPS45, and phosphatidylinositol-3cate network of signaling cascades. In the traditional
kinases (PI(3)Ks) p110/p85 and hVPS34/p150, which
act cooperatively in vesicle tethering, SNARE priming,
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somes which is enriched in phosphatidylinositol 3-phos- and specific, we cloned and in vitro translated both
APPL proteins to measure their ability to bind variousphate (PI(3)P) and a set of PI(3)P binding effectors
(Christoforidis et al., 1999b; Zerial and McBride, 2001). recombinant GST-tagged Rab proteins. Both APPL1
and APPL2 strongly bound Rab5:GTPS but neitherPI(3)P is also required for the endosomal localization of
various signaling molecules, such as a component of Rab5:GDP nor Rab4, Rab7, or Rab11 (Figure 1C), indi-
cating that they are specific effectors of Rab5. To con-the TGF- pathway SARA (Smad anchor for receptor
activation) (Hayes et al., 2002; Tsukazaki et al., 1998). firm that APPL1 and APPL2 colocalize with Rab5:GTP
in vivo, we raised antibodies against the C-terminal pep-Intriguingly, dominant-negative mutant of Rab5 affects
TGF-/activin signal transduction in endothelial cells by tides of both proteins which recognize endogenous lev-
els of the corresponding antigens and do not exhibitan as yet unknown mechanism (Panopoulou et al., 2002).
While these examples suggest a link between Rab5 any crossreactivity between them (see below). Both en-
dogenous APPL1 (Figure 1E) and APPL2 (data notand intracellular signaling, it remains open whether
components of the Rab5 machinery and the endocytic shown) accumulated on the enlarged endosomes in-
duced by expression of the constitutively active Rab5Q79Lorganelles harboring them are required for signal trans-
duction. Furthermore, whether canonical early endo- mutant (Stenmark et al., 1994). Thus, APPL proteins spe-
cifically interact with Rab5:GTP in vitro and localize tosomes are the only organelles involved in signal trans-
duction or whether specialized compartments devoted membranes harboring this protein in vivo.
to signaling exist are open questions. Here, we describe
a pathway propagating signals from the cell surface to APPL1 and APPL2 Localize
the nucleus involving two previously uncharacterized to Cytoplasmic Membranes
Rab5 effectors residing on an endosomal compartment. In contrast to other Rab5 effectors exhibiting a typical
endosomal staining pattern, we were surprised to ob-
serve a more complex intracellular distribution of APPL1Results
and APPL2. In HeLa (Figure 1F), A431, and BHK (data
not shown) cells, APPL1 localized to punctate structuresIdentification of Two Rab5 Effectors
In a search for new Rab5 effectors, mass spectrometry dispersed in the cytoplasm but mostly concentrated
underneath the plasma membrane. Similar structuresanalysis revealed that one of the most abundant proteins
(80 kDa) affinity purified on a GST-Rab5:GTPS col- were also labeled for APPL2 (Figure 1G). In addition,
both proteins were present in the nucleus. Whereasumn (Figure 1A; Christoforidis et al., 1999a) corre-
sponded to APPL (Adaptor protein containing PH do- APPL2 was particularly enriched in the nucleus with
respect to the cytoplasmic structures, the intensity ofmain, PTB domain and Leucine zipper motif; accession
number AF169797; Figure 1B), a 709 amino acid protein the nuclear staining of APPL1 varied between individ-
ual cells.previously identified in a two-hybrid screen as an inter-
acting partner of the AKT2/PKB kinase and putative Given the complexity of the staining pattern, it was
essential to exclude antibody artifacts. Five lines of evi-adaptor tethering inactive AKT2 to PI(3)K p110 (Mitsu-
uchi et al., 1999). Another two-hybrid screen described dence validate the specificity of the staining. First, both
anti-APPL1 and -APPL2 antibodies recognize singleAPPL (therein referred to as DIP13) as an interactor of
the tumor suppressor DCC (deleted in colorectal cancer) bands corresponding to the predicted protein size in
HeLa cytosol by Western blot (Figure 1D). Second, theand a mediator of DCC-induced apoptosis (Liu et al.,
2002). Further sequencing of the GST-Rab5:GTPS elu- immunofluorescence staining was abolished upon pre-
incubation of the antibodies with the respective peptideate from HeLa cytosol revealed a protein of 664 amino
acids (recently named DIP13, accession number (data not shown). Third, knocking down both genes by
siRNA drastically reduced or abolished both immunoflu-NM_018171), sharing 54% identity and the same domain
organization with APPL (Figure 1B). The two proteins, orescence and Western blot signals (Figure 7A and Sup-
plemental Figure S2 available on Cell website). Fourth,referred here as APPL1 and APPL2, are encoded by
genes on human chromosomes 3 and 12, respectively. myc epitope-tagged APPL1 and APPL2 colocalized with
the endogenous proteins in the peripheral structuresA potential nuclear localization signal on APPL2
(151PKKKENE157) but not on APPL1 was detected by PSORT and on Rab5Q79L enlarged endosomes (Figure 2A and
data not shown). Fifth, the presence of APPL1 in a puri-II program (Nakai and Horton, 1999). Furthermore, by
SMART analysis (Schultz et al., 1998) we identified a fied nuclear fraction was determined by Western blot
analysis (Figure 6A) and this signal was reduced byBAR domain (BIN1/Amphiphysin/RVS167; Sakamuro et
al., 1996) at the N terminus of APPL1 (Supplemental siRNA treatment (data not shown). Having established
the authenticity of the staining pattern, we analyzedFigure S1 available at http://www.cell.com/cgi/content/
full/116/3/445/DC1). Given the relatively high homology the APPL-positive peripheral structures in more detail.
Endogenous APPL1 largely colocalized with myc-between APPL1 and APPL2 in this region (54% identity
and 74% similarity), APPL2 is assumed to contain a BAR APPL2 in the same structures (Figure 2A), which were
also positive for GFP-Rab5 (Figure 2B). Surprisingly, lit-domain. Interestingly, PSI-Blast searches (Altschul et
al., 1997) with the BAR domain of APPL1 or APPL2, as tle overlap (below 11%) between APPL1 and EEA1, a
marker of canonical early endosomes (Figure 2C) waswell as structural predictions using 3D-PSSM (Fischer
et al., 1999) indicate that the BAR domain is distantly observed and, in contrast to EEA1 (Simonsen et al.,
1998), immunodepletion of both APPL1 and APPL2 fromrelated to arfaptins, which bind ARF and Rac GTPases
(Supplemental Figure S1 available on Cell website; Tarri- HeLa cytosol did not inhibit heterotypic and homotypic
early endosome fusion (data not shown). Lack of APPL1cone et al., 2001; Van Aelst et al., 1996).
To test whether the interaction with Rab5 is direct colocalization with caveolin1-GFP (Pelkmans et al.,
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Figure 1. APPL1 and APPL2 Are Rab5 Effectors
(A) Coomassie-stained cytosolic proteins interacting specifically with Rab5:GTPS.
(B) Domain structure of APPL1 and APPL2 proteins.
(C) APPL1 and APPL2 interact specifically with Rab5:GTPS. In vitro translated, [35S]methionine labeled APPL proteins were incubated with
beads loaded with GST-Rab proteins in the GDP or GTPS forms; bound proteins were analyzed by SDS-PAGE and autoradiography.
(D) Peptide antibodies to APPL1 and APPL2 recognize single bands in HeLa cytosol by Western blot.
(E) Endogenous APPL1 localizes to Rab5Q79L-enlarged endosomes in vivo. HeLa cells were transfected with Rab5Q79L and stained with
antibodies to APPL1. The transfected cell is indicated with an asterisk.
(F and G) Distribution of endogenous APPL1 and APPL2 in HeLa cells, stained with specific antibodies as indicated. Individual confocal
sections are shown in (E–G). Scale bar is equal to 20 m.
2001; Figure 2D) and -adaptin (data not shown) elimi- ther via receptor-mediated (transferrin) or fluid-phase
endocytosis (dextran). We observed only a low degreenated the possibility that APPL-positive structures cor-
responded to caveolae/caveosomes and clathrin-coated (below 10%) of APPL1 colocalization with internalized
transferrin (Figure 4A) and no significant labeling withvesicles, respectively.
To confirm that the punctate pattern of APPL1 repre- dextran (data not shown) at any time point, arguing that
APPL-positive structures are not pinosomes. Given thatsented membrane structures and not some protein-
aceous particles, we performed immunoelectron mi- the machineries responsible for constitutive (transferrin)
and ligand-induced (growth factors) endocytosis can becroscopy on frozen sections. Specific labeling for APPL1
was associated with both tubular and vesicular mem- differentially regulated (Di Fiore and De Camilli, 2001),
we tested whether rhodamine-labeled EGF (Rh-EGF)brane structures generally in close proximity to the
plasma membrane (Figure 3). These data clearly estab- could access APPL structures. Cells were serum-starved
overnight and Rh-EGF was internalized for 5, 15, or 30lish that the APPL-labeled structures are membrane
bound, consistent with the fact that APPL1 was detect- min in order to progressively label clathrin-coated vesi-
cles, early endosomes, and late endosomes/lysosomes.able in preparations of endosomal membrane isolated
by floatation on density gradients (data not shown). The Unexpectedly, we observed that the APPL1 distribution
changed dramatically upon serum starvation and EGFlack of colocalization with EEA1 observed by immunoflu-
orescence microscopy raises the possibility that these stimulation (Figure 4B). In serum-starved cells, APPL1
was restricted to the punctate structures in cytosol andstructures may be different subcompartments of early
endosomes or even a distinct type of endosomes, a absent from the nucleus. In sharp contrast, upon treat-
ment of cells with Rh-EGF for 5 min, APPL1 partly trans-possibility that requires further investigation.
located from the peripheral structures to the cytoplasm,
became particularly enriched on the nuclear envelopeEGF Is Internalized into APPL Structures
and Causes APPL1 Redistribution and began to appear in the nucleus. Within 15 min of
Rh-EGF treatment, APPL1 shifted from the cytoplasmWe next set out to determine whether the APPL struc-
tures are accessible to endocytic cargo internalized ei- to the nucleus and after 30 min its accumulation in the
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Figure 2. Morphological Characterization of Intracellular Structures Labeled by APPL Proteins
APPL1 and APPL2 colocalize with each other (A) and Rab5 (B) but not EEA1 (C) or caveolin (D) in peripheral punctate structures. HeLa cells
were transfected with the indicated plasmids, fixed and stained with antibodies to APPL1, myc, or EEA1. Arrowheads in (A) and (B) indicate
the structures shared between APPL1 and myc-APPL2 or Rab5, respectively. Arrows in (B) mark the Rab5-positive structures, which do not
contain APPL1. Individual confocal sections are shown. Scale bar is equal to 20 m.
nucleus subsided and the typical membrane labeling tive clathrin-coated vesicles (Rubino et al., 2000). At 15
min, Rh-EGF appeared in EEA1-containing early endo-reappeared. The response of APPL1 to EGF indeed cor-
related with the accessibility of APPL1-positive mem- somes (Figure 5A) that expanded in size as shown pre-
viously (Barbieri et al., 2000) and colocalization withbranes to this growth factor (Figure 4C). After 5 min of
internalization, a fraction of Rh-EGF (between 5%–28%) APPL1 was no longer detectable. These data illustrate
two main points. First, the APPL structures are endo-localized to fine punctate structures harboring APPL1
(the extent of colocalization varied depending on the somes accessible to cargo such as EGF, but poorly if
any, transferrin. Second, APPL1 undergoes regulateddegree of APPL1 solubilization). At this point, the
majority of Rh-EGF (70%–90%) was present in EEA1- cycles of redistribution between endosomes and the
nucleus in response to EGF. Unfortunately, the exclusionpositive early endosomes and, presumably, EEA1-nega-
APPL Proteins Link Rab5 to Signal Transduction
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Figure 3. Electron Microscopic Localization
of Endogenous APPL1
Serum-starved A431 cells were fixed with
paraformaldehyde and processed for frozen
sectioning. Sections were labeled with anti-
bodies to APPL1 followed by 10 nm protein
A-gold. Specific labeling (arrowheads) is as-
sociated with membrane structures that vary
in morphology, predominantly located close
to the plasma membrane (pm). The figure
shows a gallery of representative labeled
structures, which include small vesicles (A),
vacuolar structures (B) and tubular profiles
(C). Scale bar is equal to 100 nm.
of GFP-labeled APPL from the nucleus prevented the uptake in cells expressing a dominant-negative mutant
(K44A) of dynamin II (Vieira et al., 1996). Strikingly, al-possibility to capture this interesting process by video
microscopy. though dynaminK44A blocked the transport of EGF into
early and late endosomes, as evidenced by the lack ofWe next tested whether the APPL1 cycle in response
to EGF depended on dynamin by performing Rh-EGF enlarged endosomes labeled with Rh-EGF (Figure 5,
Figure 4. EGF, but Not Transferrin, Is Internalized into APPL Structures and Causes APPL1 Redistribution
(A) HeLa cells were serum-starved for 1 hr and incubated with 30 g/ml of rhodamine-transferrin (Rh-Tf) for 5 min at 37C, fixed, and stained
with antibodies to APPL1. The degree of colocalization between APPL1 and Rh-Tf was not increased upon longer internalization times (30 min).
(B) HeLa cells were serum-starved overnight and incubated with 1 g/ml Rh-EGF for 5, 15, or 30 min at 37C, fixed, and stained with anti-
APPL1 antibodies.
(C) HeLa cells were treated with Rh-EGF for 5 min, fixed, and stained with antibodies to APPL1 or EEA1. Arrowheads in (C) indicate the
structures labeled by EGF and EEA1, while arrows indicate the EGF- and APPL1-positive membranes. Individual confocal sections are shown.
Scale bar is equal to 20 m.
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Figure 5. Release of APPL1 from Mem-
branes Is Dependent on Rab5:GTP but Not
Dynamin
(A–B) Control HeLa cells (A) or cells trans-
fected with dynaminK44A-GFP (B) were serum-
starved overnight, incubated with Rh-EGF for
15 min at 37C, fixed, and stained with anti-
bodies to EEA1 or APPL1, as indicated.
(C–E) APPL proteins associate with the mem-
brane in a Rab5-dependent manner.
(C and D) HeLa cells were transfected with
Rab5S34N or RN-tre, fixed, and stained with
antibodies to APPL1. The transfected cells
are indicated with an asterisk.
(E) HeLa cells were treated with 1 mM H2O2
for 15 min, fixed, and stained with antibodies
to APPL1. Scale bar is equal to 10 m.
compare A with B, 15 min Rh-EGF), a fine punctate upon treatment of HeLa cells with H2O2 for 15 min, we
observed a progressive loss of APPL1 from the periph-labeling of EGF resembling the APPL1 staining and un-
derlying plasma membrane was observed (Figure 5B). eral structures and its accumulation in the nucleus (Fig-
ure 5E). These results provide strong evidence thatImportantly, dynaminK44A did not affect the translocation
of APPL1 to the nucleus (Figure 5B). In contrast, blocking membrane localization of APPL1 depends primarily on
the active Rab5 and is sensitive to GTP hydrolysis orEGF endocytosis at 4C prevented release of APPL1
and its nuclear translocation (data not shown), sug- reduction in Rab5:GTP levels. Moreover, similar to EGF
stimulation, oxidative stress is another signaling path-gesting that APPL signaling requires EGF internalization
and is not triggered by EGF binding to its receptor on way that relocates APPL1 to the nucleus.
the surface or deeply invaginated pits (Vieira et al., 1996).
Collectively, EGF internalization into APPL-positive en- APPL Proteins Interact with Components
dosomes and EGF-dependent release of APPL1 from of Nucleosome Remodeling and Histone
them appears to operate dynamin independently. Deacetylase Complex NuRD/MeCP1
and Are Required for Cell Proliferation
We used subcellular fractionation to verify that a poolGTP Hydrolysis by Rab5 Releases APPL1
from Endocytic Structures in Response of APPL1 is present in the nucleus and is dynamically
modulated by signaling molecules, in agreement withto Extracellular Stimuli
By which mechanism is APPL1 released from endo- the immunofluorescence experiments. Purified nuclei
devoid of endosomal contaminants, e.g., Rab5 or EEA1,somes? GTP hydrolysis on Rab5 could potentially disen-
gage APPL1 from the membranes since APPL binding were found to contain APPL1 and this pool was reduced
upon serum deprivation (Figure 6A). To gain further in-to Rab5 is GTP-dependent. We tested this possibility in
three ways. First, a dramatic redistribution of endoge- sights into the function of APPL1, we undertook a search
for interacting partners by coimmunoprecipitation ex-nous APPL1 (Figure 5C) from the membranes to the
cytosol was observed in cells expressing Rab5S34N, a periments from cytosol and detergent extracts of HeLa
cells. Whereas no proteins were coimmunoprecipitatedmutant preferentially GDP bound. Second, overexpres-
sion of the Rab5 GAP RN-tre (Lanzetti et al., 2000) with APPL1 from cytosol (data not shown), a number
of proteins were recovered from the detergent extractcaused a substantial displacement of APPL1 from the
peripheral structures, consistent with the reduction of (Figure 6B). Surprisingly, mass spectrometry sequenc-
ing revealed the presence of PID/MTA2, p66, HDAC1,the pool of active Rab5 in these cells (Figure 5D). Third,
we took advantage of the fact that under oxidative and/or HDAC2 (identified through common peptides)
RbAp46, RbAp48, and MBD3, namely 6 out of 10 compo-stress, phosphorylation of RabGDI by p38MAPK results
in extraction of Rab5 and its effector EEA1 from the nents of the nucleosome remodeling and histone de-
acetylase NuRD/MeCP1 complex (Feng and Zhang,early endosomes (Cavalli et al., 2001). Consistently,
APPL Proteins Link Rab5 to Signal Transduction
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Figure 6. APPL Proteins Interact with the
Components of the Nucleosome Remodeling
and Histone Deacetylase Complex NuRD/
MeCP1
(A) A pool of APPL1 is present in the nucleus
and is decreased in serum-starved cells. Nu-
clei were prepared from HeLa cells grown
with or without serum and analyzed for the
presence of APPL1 and indicated markers by
Western blot (load of 100 g total protein).
Cytosol from serum-grown HeLa cells (100
g) was loaded as a control.
(B) Coomassie-stained proteins coimmuno-
precipitated from HeLa detergent extracts by
antibody to APPL1.
(C) Western blot detection of PID/MTA2 and
RbAp46 immunoprecipitated from HeLa nu-
clear extracts by antibodies to APPL1 and
APPL2 and a preimmune (PI) serum.
(D) GST pulldown of proteins interacting with
APPL1 and APPL2. HeLa nuclear extracts were incubated with the beads loaded with GST alone or fused to APPL1 or APPL2. PID/MTA2
and RbAp46 retained on the columns were detected by Western blot.
2001). Given the reported nuclear localization of the in- staining. Flow cytometric analysis of DNA content indi-
cated that knockdown of APPL proteins did not elicit ateracting proteins and of APPL1 (Figure 6A), we con-
firmed the specificity of the coimmunoprecipitation us- specific cell cycle arrest (Figure 7C). Collectively, the
interaction with the NuRD/MeCP1 complex togethering HeLa nuclear extracts. Western blot analysis (Figure
6C) showed that antibodies to APPL1 but not preimmune with the effects on DNA replication suggest that APPL
proteins exhibit essential functions in a signaling path-serum efficiently and specifically coimmunoprecipitated
PID/MTA2 protein and, to a lesser extent, also RbAp46. way leading to cell proliferation.
We could not observe a similar interaction using APPL2
antibodies presumably due to their low efficiency in im- Binding to Rab5 Is Indispensable
for the Functional Cycle of APPL1munoprecipitation. We furthermore confirmed these in-
teractions by GST pull-down experiments applying nu- We further wished to test whether the interaction be-
tween Rab5 and APPL is critical for the regulation ofclear extracts to columns with immobilized GST alone
or fused to APPL proteins (Figure 6D). PID/MTA2 and cell proliferation. We first conducted deletion mutagene-
sis and in vitro binding studies to identify sequencesRbAp46 were specifically bound to GST-APPL1 but not
GST alone. Interestingly, we also recovered these pro- engaged in Rab5 binding on the APPL1 molecule (Figure
7D). Based on the homology of the BAR domain to arfap-teins on the GST-APPL2 column, suggesting that both
APPL proteins can interact with the components of tins we focused on this region of APPL1 as the potential
binding site. Strikingly, the presence of both BAR andNuRD/MeCP1 in the nucleus.
Histone deacetylase activities are required for cell cy- PH domains (residues 1–428) was necessary for binding
to Rab5:GTP, suggesting that one domain may stabilizecle progression and development (Ahringer, 2000; Yo-
shida et al., 1995). The identification of the NuRD/MeCP1 the other or both may cooperatively bind Rab5. In con-
trast to some PH domains that can bind specific mem-complex as a binding partner together with the nuclear
localization of APPL1 and APPL2 prompted us to investi- branes due to high affinity for certain phosphoinositides
(Dowler et al., 2000), the PH domain of APPL1 was notgate their function with respect to cell proliferation. We
assayed DNA synthesis under downregulation of endog- sufficient for membrane targeting. Remarkably, when
overexpressed in vivo as fluorescently tagged proteins,enous APPL proteins by RNA interference (Elbashir et
al., 2001). Forty-eight hours after transfecting the cells only mutants capable of interacting with Rab5 exhibited
membrane localization, underscoring the function ofwith small interfering RNA oligonucleotides specific for
APPL1 or APPL2, we observed a pronounced reduction Rab5 as a primary determinant of APPL localization to
the endosomes (Figure 7D).in protein levels of APPL1 and/or APPL2, as evidenced
by Western blot (Figure 7A) and immunofluorescence We further investigated the effect of the truncation
mutants on DNA synthesis, as measured by BrdU incor-analysis (Supplemental Figure S2 available on Cell web-
site). Strikingly, by measuring BrdU incorporation we poration (Figure 7D). While the overexpressed wild-type
or APPL1 mutants capable of Rab5 binding (532709,observed that knockdown of either APPL1 or APPL2
resulted in a 50% reduction in the number of cells enter- 429709) did not affect the rate of DNA synthesis,
all mutants unable to interact with Rab5 elicited someing S phase in comparison with control cells (mock-
treated or transfected with unrelated siRNA; Figure 7B). inhibitory effects on this process. In particular, the ex-
pression of APPL11-272 lacking the BAR domain andThe inhibitory effects on DNA synthesis elicited by
knockdown of either APPL1 or APPL2 were not additive unable to bind Rab5 completely blocked BrdU incor-
poration. Since the mutant protein accumulated in the(Figure 7B), arguing that the two proteins cannot substi-
tute for each other. No increase in cell death was evident cytosol and was excluded from the nucleus, its antipro-
liferative activity in all likelihood depends on the seques-under these conditions, as determined by Trypan blue
Cell
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Figure 7. APPL1 and APPL2 Are Required for
Cell Proliferation and Rab5 Binding Is Essen-
tial for Their Function
(A) Reduced levels of APPL1 and APPL2 48
hr after transfecting HeLa cells with siRNA
oligos, as detected by Western blot.
(B) Histogram showing the percentage of
cells incorporating BrdU (1 hr pulse) 48 hr
after transfection with siRNA oligos. Typi-
cally, about 50%–60% of control cells
showed BrdU incorporation under these con-
ditions.
(C) DNA content of cells 48 hr after transfec-
tion with siRNA oligos measured by flow cy-
tometry.
(D) Schematic representation of APPL1 mu-
tants. Rab5 binding was assayed biochemi-
cally as in Figure 1C. All mutants were stably
expressed in reticulocyte lysate. Intracellular
localization was tested by transfecting YFP
fusion constructs in HeLa cells (N, nucleus;
C, cytosol; M, cytosolic membranes). Per-
centage of BrdU incorporation was deter-
mined in cells transfected with YFP fusion
constructs (BrdU incorporation in cells trans-
fected with YFP alone was set to 100%).
tration of yet unidentified soluble factors acting prior that (1) binding to Rab5 and (2) cytoplasmic interactions
following the release from endosomes constitute essen-to nuclear import of APPL1. Moreover, expression of
APPL1320-705 comprising the BAR domain caused tial steps of the functional cycle of the APPL1 protein.
increased cell death, indicating that interference with
the activity of APPL may induce a proapoptotic effect. Discussion
To avoid a possibility that, in addition to Rab5 binding,
other APPL1 functions have been affected by introduc- We report here the discovery of a previously unidentified
signal transduction pathway between the plasma mem-ing large domain deletions, we performed a random
mutagenesis on the residues 1–428 of APPL1 (BAR and brane and the nucleus. First, this pathway involves two
new Rab5 effectors, APPL1 and APPL2, that are local-PH domains) selecting for point mutations abolishing
interaction with Rab5 in vitro and membrane localization ized to an endocytic compartment, which receives low
amounts of internalized cargo such as EGF suggestingin vivo. A mutant fulfilling these criteria carried 3 amino
acid changes within the PH domain (K280E, Y283C, a specific role in signaling rather than housekeeping
endocytosis. Second, following EGF internalizationG319R). Assuming that the PH domain of APPL1 adopts
the same fold as the crystallized RhoGEF Tiam1 (Wor- APPL1 is released from the membrane and translocates
to the nucleus. Third, this release depends on thethylake et al., 2000), these mutations are unlikely to dis-
rupt the structural core of the domain, being located in GTPase cycle of Rab5, an established regulator of endo-
cytosis. Fourth, both APPL1 and APPL2 proteins interactloop regions possibly involved in intra- or intermolecu-
lar interactions. Similarly to the truncated proteins with components of the nucleosome remodeling and
histone deacetylase complex NuRD/MeCP1 and are re-unable to interact with Rab5, both the APPL1 and
APPL1429709 triple point mutants remained cyto- quired for efficient cell proliferation. Fifth, mutagenesis
analysis indicates that the interaction of APPL1 withsolic, did not localize to Rab5Q79L enlarged endosomes
and elicited a dominant-negative inhibition of BrdU in- Rab5 is essential for the regulation of cell proliferation.
Our data raise important implications concerning thecorporation (Figure 7D). Collectively, these data suggest
APPL Proteins Link Rab5 to Signal Transduction
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role of membrane compartmentalization and endocytic Rab5-positive membranes. Such physical segregation
would provide the advantage of independent regulationtransport in signal transduction.
of the Rab5 GTP/GDP cycle in response to growth fac-
tors as compared with a single compartment. The Rab5EGF Signaling Via APPL Endosomes
GEF RIN1 and the GAP RN-tre are subjected to regula-EGF uptake is traditionally a hallmark of clathrin-, dyn-
tion by EGF (Barbieri et al., 2000; Lanzetti et al., 2000; Tallamin- and Rab5-dependent endocytosis (Lanzetti et al.,
et al., 2001) and, thus, these or some yet uncharacterized2000; Vieira et al., 1996). The existence of an EGF entry
family members could regulate the Rab5 cycle on APPLroute into an APPL-positive compartment indicates that
endosomes. It is conceivable that the kinetics of thethis view is incomplete. Since only a minor pool of EGF
Rab5 nucleotide cycle may also determine the residenceis internalized into APPL structures, the physical se-
time of EGF in APPL endosomes. Following GTP hydro-questration of EGF in this subcompartment may fulfill a
lysis, the level of Rab5:GTP must be reequilibrated tosignaling role rather than ligand-receptor downregula-
restore the localization of APPL proteins to the mem-tion. Importantly, our data shed more light onto the semi-
brane within 30 min of EGF stimulation (Figure 4B). Innal findings by Schmid and colleagues (Vieira et al.,
addition, reactivation of Rab5 would enable clearance of1996), who reported an enhancement of EGF-dependent
EGF from the APPL endosomes and its further traffickingproliferation in cells where clathrin-mediated endocyto-
along the canonical endocytic route. This possibilitysis was inhibited via the dominant-negative dynaminK44A
is supported by (1) the finding that expression ofmutant. A residual EGF uptake (30%) was observed un-
Rab5Q79L relocates APPL proteins to enlarged endo-der these conditions. Our data suggest that at least a
somes, suggesting a mixing of the two compartmentsfraction of this pool is most likely internalized into APPL-
and (2) a certain degree of colocalization between APPLpositive endosomes. The data of Schmid and colleagues
and EEA1 structures.argue further that even if EGF signaling takes place on
Our data uncover an essential role of APPL proteinscanonical early endosomes, it is dispensable for the
in a pathway leading to cell proliferation. By which mech-mitogenic response. In contrast, we demonstrate that
anisms could APPL proteins exert this function? TwoAPPL-dependent signaling pathways are required for
important clues were provided by the observations thatefficient cell proliferation, pointing to functional differ-
APPL proteins undergo nucleocytoplasmic shuttlingences between signals emitted from various endosomal
and interact with the NuRD/MeCP1 complex. As histonecompartments. EGF elicits activation of intracellular sig-
deacetylase activities are required for cell cycle progres-naling cascades through a subclass of high affinity re-
sion (Yoshida et al., 1995), APPL binding to NuRD/ceptors constituting only 5%–10% of the total EGFR
MeCP1 may serve the purpose of subjecting this func-pool (Defize et al., 1989). Since loss of dynamin function
tion to regulation by extracellular signaling molecules.does not impair mitogenic signaling upon EGF stimula-
To our knowledge, there are no data linking the histonetion (Vieira et al., 1996), an exciting possibility raised by
deacetylase/chromatin remodeling activities to endocy-our observations is that at least a fraction of the subclass
tosis and our findings may indicate the first example ofof high affinity receptors may escape the dynamin block
such regulation. Our data delineate a multistep processand signal via the Rab5-APPL-mediated signaling
in which (1) the interaction with Rab5 followed by (2)pathway.
the release from endosomes triggered by extracellular
signals and (3) the import from cytoplasm to the nucleus
Coupling the GTPase Cycle of Rab5 constitutes crucial steps of the APPL1 cycle. Interest-
to Signal Transduction ingly, the interaction with Rab5 appears to be part of a
Remarkably, our study indicates that the cell utilizes the control mechanism to couple the release of APPL1 from
simplest mechanism to couple the regulation of receptor the endosomes to growth factor signaling and traffick-
trafficking to that of growth factor signaling: the shared ing. Our mutagenesis analysis in fact points at the Rab5-
GTPase switch of Rab5. We propose a model whereby dependent localization being a prerequisite for down-
such regulation is exploited both in time and space. stream cytoplasmic interactions that are required for
Rab5 is present on distinct intracellular organelles: transmitting proliferative signals. This hypothesis is sup-
plasma membrane, clathrin-coated vesicles, and early ported by the findings that all mutants unable to interact
endosomal compartments, such as EEA1-positive en- with Rab5 accumulated in cytosol and/or nucleus and
dosomes, where it recruits different sets of effectors exerted dominant-negative effects on DNA synthesis.
(Bucci et al., 1992; Christoforidis et al., 1999b; Miaczyn- These effects are most likely due to interference with the
ska and Zerial, 2002; Rubino et al., 2000). Upon EGF activity of endogenous APPL1 through sequestration of
stimulation, Rab5 is activated at the plasma membrane cytoplasmic and/or nuclear factors. Although our data
and on EEA1-positive early endosomes, allowing for effi- point at the nucleus as a primary site of APPL-NuRD/
cient EGF internalization and further transport to early MeCP1 complex interactions, we cannot exclude that
endosomes, late endosomes, and lysosomes (Barbieri these may also take place in the cytoplasm, as we ob-
et al., 2000; Lanzetti et al., 2000). Stimulation of GTP served significant cytoplasmic pools of PID/MTA2 and
hydrolysis by Rab5 is, in contrast, required for the re- RbAp46 in addition to their nuclear localization (Figure
lease of APPL1 from the membrane. Our data imply that 6A and data not shown), as also reported for PID/MTA2
this dual regulation of the kinetics of the GTPase cycle (Humphrey et al., 2001). However, these components
exploits the physical separation of APPL from the ca- do not colocalize with APPL proteins on Rab5Q79L en-
nonical Rab5-, EEA1-, and PI(3)P-transport machinery. larged endosomes (data not shown), suggesting that
APPL proteins may be localized to a subcompartment Rab5-APPL and APPL-NuRD/MeCP1 binding might be
mutually exclusive. Continuous rounds of binding ofof early endosomes, if not to a distinct population of
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APPL1 to Rab5 and dissociation from the membrane via APPL proteins could be directly linked to chromatin
remodeling, a process of crucial importance in develop-may be necessary to ensure the reversibility of interac-
tions with downstream factors but also regulate their ment. This view is supported by recent studies demon-
strating that the components of C. elegans NuRD areactivity. For example, it is plausible that posttransla-
tional modifications or conformational changes taking required for embryonic viability, patterning, and Ras sig-
naling (Ahringer, 2000; Lu and Horvitz, 1998; Unhavai-place on the Rab5-positive membranes may regulate
the ability of APPL1 to functionally interact with other thaya et al., 2002). APPL proteins do not have homologs
in C. elegans or Drosophila but are present in all verte-partners, e.g., the NuRD/MeCP1 complex, making cy-
cling through endosomes an obligatory step in APPL sig- brates and could play a signaling role during develop-
ment, e.g., in axon guidance (Liu et al., 2002).naling.
In summary, the identification of a signaling pathway
involving the APPL proteins opens several exciting linesCellular Functions of APPL Proteins
of investigation. The Rab5-dependent regulatory cycleWith the discovery of the interaction with Rab5 and the
of APPL proteins and their residence on an endosomallocalization to endosomes, some of the earlier data on
(sub)compartment raise possibilities for therapeutic in-APPL1 will now have to be reexamined. Originally,
tervention based on antiproliferative agents without af-APPL1 was shown to interact with the inactive form of
fecting the housekeeping functions of the early endo-the multifunctional antiapoptotic kinase AKT2 (Mitsu-
somes. Further dissection of the function of the APPLuchi et al., 1999). Since inactive AKT kinases are pre-
proteins will likely bring unexpected insights into howdominantly cytosolic, it is unlikely that AKT2 colocalizes
ligand-stimulated, Rab5-mediated endocytosis can af-with APPL proteins on endosomes. Another reported
fect chromatin structure, gene expression, and apo-interactor of APPL1 is the tumor suppressor DCC, a
ptosis.plasma membrane receptor for an axon-guiding mole-
cule netrin-1 (Keino-Masu et al., 1996; Liu et al., 2002).
Experimental ProceduresIn the absence of ligand, DCC induces apoptosis via
activation of caspase-3 and -9 in a process that requires Rab5 Affinity Chromatography, APPL Cloning, Antibody
APPL1 (Forcet et al., 2001; Liu et al., 2002). Neither the Production, and Random Mutagenesis
GST-Rab5 affinity chromatography with cytosol or in vitro translatedintracellular trafficking nor the ligand-dependence of the
proteins was performed as described (Christoforidis et al., 1999a,DCC-APPL1 interaction has been addressed, but an at-
1999b). APPL1 and APPL2 were cloned from human full-length adulttractive possibility suggested by our work is that DCC
leukocyte cDNA library (Invitrogen Life Technologies) and by RT-could signal via APPL endosomes in neurons. Another
PCR from HeLa mRNA, respectively. Peptides SSSQSEESDLGEGG
exciting implication of our data concerns the possible KKRESEAC and NDQPDDDDGNPNEHRGAC derived from the
link between APPL-mediated processes, such as DCC- sequence of APPL1 and APPL2, respectively, were synthesized and
injected into rabbits (Eurogentec, Belgium). Sera were affinity puri-induced apoptosis, to the action of p53, one of the sub-
fied using peptides immobilized on Sulfolink beads (Pierce). Randomstrates of NuRD/MeCP1. Activation of p53 induces ei-
mutagenesis was performed using Diversify PCR Kit (Clontech).ther growth arrest or apoptosis, depending on the set
of its transcriptional targets activated under various con-
Protein Identification by Mass Spectrometry
ditions (Vousden, 2000). In this context, it appears par- Gel separated, Coomassie-stained proteins were excised from the
ticularly interesting that deacetylation of p53 mediated gel slab and in-gel digested with trypsin as described (Shevchenko
et al., 1996). Tryptic peptides were sequenced by nanoelectrosprayby a direct interaction with PID/MTA2 (one of the most
tandem mass spectrometry on hybrid quadrupole time-of-flightabundant proteins in the APPL1 immunoprecipitate) re-
mass spectrometers Q-TOF I (Micromass Ltd, Manchester, UK) andduces its activity and apoptotic potential (Luo et al.,
QSTAR Pulsar i (MDS Sciex, Concord, Canada) as described (Shev-2000). Notably, the BAR domain of amphiphysinII/BIN1
chenko et al., 1997). Database searching was performed by Mascot
has been shown to possess proapoptotic activity (Elliott software (Matrix Science, Ltd., London).
et al., 2000) and we observed increased cell death upon
overexpression of the BAR domain of APPL1 (Figure 7D). Cell Culture, Transfections, Immunofluorescence,
Immunoelectron Microscopy, Endosome Fusion AssayWe anticipate that the function of APPL proteins is
and BrdU Incorporation, and Flow Cytometry Analysisnot restricted to the response to a single growth factor
HeLa and A431 cells were grown and immunofluorescence labeling(EGF) but that these proteins act at the crossroad of
was performed according to standard procedures. MetaMorph6.1r3
several signaling pathways. The observed release of program (Universal Imaging Corp.) was used for quantifying the
APPL1 from the endosomes upon oxidative stress con- percentage of overlap between immunofluorescence signals. For
transient expression studies, cells were transfected using FuGENEfirms this prediction. It is appealing to consider that
6 (Roche) and analyzed 20 hr posttransfection. For immunoelectronthe fraction of growth factors sorted into APPL- versus
microscopy, cells were processed for frozen sections as describedcanonical early endosomes and the resulting differences
(Luetterforst et al., 1999). BrdU incorporation was performed usingin the quality of generated signals may be regulated
Labeling and Detection Kit (Roche). Endosome fusion assay was
depending on the cell type or developmental stage, as performed as described (Horiuchi et al., 1997). Antibodies against
it is known that the same growth factor can elicit either PID/MTA2, RbAp46, and PCNA were obtained from Oncogene Re-
search Products, Affinity BioReagents Inc. and BD Transductionproliferation or differentiation response in various cells
Laboratories, respectively. Flow cytometry analysis was performed(Yarden, 2001). Interestingly, an inhibition of DNA syn-
as described (Liu and Erikson, 2003).thesis upon knocking down APPL proteins seems to be
a more general phenomenon, as it was observed also
siRNA Preparation and Transfection
in cell lines derived from colon (DLD-1) and breast (MDA- Duplex siRNA (APPL1: 5	-CACACCUGACCUCAAAACUTT and 5	-
MB-231) cancer (our unpublished data). The observed AGUUUUGAGGUCAGGUGUGTT; APPL2: 5	-GUGGUGGAUGAGCU
UAAUCTT and 5	-GAUUAAGCUCAUCCACCACTT) were purchasedAPPL-NuRD/MeCP1 interaction suggests that signaling
APPL Proteins Link Rab5 to Signal Transduction
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from Proligo (Paris, France) and transfected using Oligofectamine Phosphoinositide-3-kinases are Rab5 effectors. Nat. Cell Biol. 1,
249–252.(Invitrogen).
Defize, L.H., Boonstra, J., Meisenhelder, J., Kruijer, W., Tertoolen,
Preparation of Nuclei, Immunoprecipitation, L.G., Tilly, B.C., Hunter, T., van Bergen en Henegouwen, P.M.,
and GST Pulldown Moolenaar, W.H., and de Laat, S.W. (1989). Signal transduction by
Nuclei from HeLa cells were prepared as described (Ryseck et al., epidermal growth factor occurs through the subclass of high affinity
1989). For large-scale immunoprecipitation and GST pulldown receptors. J. Cell Biol. 109, 2495–2507.
sHeLa cells grown in suspension (4 l) were pelleted, broken in the Di Fiore, P.P., and De Camilli, P. (2001). Endocytosis and signaling:
lysis buffer (50 mM HEPES [pH 7.4], 150 mM KCl, 2 mM MgCl2) an inseparable partnership. Cell 106, 1–4.
by 10 passages through a cell cracker (EMBL, Heidelberg), and
Dowler, S., Currie, R.A., Campbell, D.G., Deak, M., Kular, G., Downes,fractionated by centrifugation to obtain nuclei (4000
 g) and cytosol
C.P., and Alessi, D.R. (2000). Identification of pleckstrin-homology-(100,000
 g). To produce total or nuclear detergent extracts, sHeLa
domain-containing proteins with novel phosphoinositide-bindingcells or nuclei were homogenized in the lysis buffer containing 1%
specificities. Biochem. J. 351, 19–31.Triton X-100, followed by 3 hr solubilization with rotation at 4C and
centrifugation at 100,000 
 g to remove particulate material. For Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K.,
immunoprecipitations, antibodies were crosslinked with dimethyl and Tuschl, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA
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